| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JPS.2600621111 |
| P698 | PubMed publication ID | 4758075 |
| P2093 | author name string | Kaplan SA | |
| Alexander K | |||
| Jack ML | |||
| Weinfeld RE | |||
| P2860 | cites work | The open field of pharmacology | Q71274825 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diazepam | Q210402 |
| pharmacokinetics | Q323936 | ||
| P304 | page(s) | 1789-1796 | |
| P577 | publication date | 1973-11-01 | |
| P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
| P1476 | title | Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. | |
| P478 | volume | 62 |
| Q51254230 | A clinical appraisal of diazepam |
| Q73848871 | A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes |
| Q51414039 | A modified simple and rapid reversed phase liquid chromatographic method for quantification of diazepam and nordiazepam in plasma. |
| Q40359652 | A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding |
| Q34449952 | A radioreceptor assay to study the affinity of benzodiazepines and their receptor binding activity in human plasma including their active metabolites |
| Q48158893 | A suicide involving intraperitoneal injection of pentobarbital. |
| Q51854342 | Acute effects of drug administration and withdrawal on the benzodiazepine receptor |
| Q42671116 | An integrated study of pharmacokinetics and pharmacodynamics of chlormethiazole in healthy young volunteers. |
| Q40142216 | Anticonvulsant drugs. An update |
| Q34359667 | Antiepileptic Drugs: Biotransformation, Metabolism, and Serum Half-Life |
| Q52795932 | Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. |
| Q49054817 | Associative control of tolerance to the sedative and hypothermic effects of chlordiazepoxide |
| Q22305844 | Benzodiazepine Poisoning Clinical and Pharmacological Considerations and Treatment |
| Q52270013 | Benzodiazepines: selective use to avoid addiction. |
| Q51861504 | Blood levels of diazepam after endotracheal administration in dogs. |
| Q40215881 | Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action |
| Q39161146 | Changes in the oral absorption characteristics in man of dipotassium clorazepate at normal and elevated gastricpH |
| Q51870675 | Clearance of diazepam can be impaired by its major metabolite desmethyldiazepam. |
| Q39720641 | Clinical Pharmacokinetics of Diazepam |
| Q51864700 | Clinical bioavailability evaluation of a controlled release formulation of diazepam. |
| Q28290502 | Clinical pharmacokinetics of acamprosate |
| Q40958204 | Clinical pharmacokinetics of diazepam and its biologically active metabolites (author's transl) |
| Q38344189 | Clinical pharmacokinetics of non-opiate abused drugs |
| Q34136303 | Comparing single and cumulative dosing procedures in human triazolam discriminators |
| Q51875774 | Comparison of flunitrazepam and thiopentone for induction of general anaesthesia |
| Q50153894 | Comparison of the pharmacokinetics of diazepam after single and subchronic doses |
| Q51861477 | Comparison of thiopentone and midazolam for induction of anaesthesia: influence of diazepam premedication. |
| Q34081090 | Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references |
| Q39221869 | Dependence, Tolerance, and Addiction to Benzodiazepines: Clinical and Pharmacokinetic Considerations |
| Q72145456 | Design of a potent and orally active nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist |
| Q58173731 | Determination of Diazepam and Nordiazepam in the Plasma of Psychiatric Patients in Long-Term Treatment Employing Liquid-Liquid and Solid Phase Extraction by Gas Chromatography with Electron Capture Detection |
| Q67600520 | Determination of chlordiazepoxide, diazepam, and their major metabolites in blood or plasma by spectrophotodensitometry |
| Q66700926 | Determination of clorazepate and its major metabolites in blood and urine by electron capture gas-liquid chromatography |
| Q51651725 | Diazepam absorption: effects of age, sex, and Billroth gastrectomy. |
| Q43479079 | Diazepam actions and plasma concentrations following ethanol ingestion |
| Q39188748 | Diazepam and Lorazepam for Intravenous Surgical Premedication |
| Q34518792 | Diazepam and N-desmethyldiazepam concentrations in saliva, plasma and CSF |
| Q51877820 | Diazepam and N-desmethyldiazepam in saliva of hospital inpatients. |
| Q51874640 | Diazepam and lorazepam compared as sedatives for outpatient third molar surgery |
| Q34512543 | Diazepam pharmacokinetics after intravenous administration in alcohol withdrawal |
| Q51798441 | Differences in diazepam pharmacokinetics in Chinese and white Caucasians--relation to body lipid stores. |
| Q51869737 | Disposition of intravenous diazepam in young men and women. |
| Q36822423 | Drug disposition and effect in sub-human primates used in pharmacology |
| Q70302862 | Drug pharmacokinetics and the carbon dioxide breath test |
| Q51238234 | Duration of benzodiazepine clinical activity: lack of direct relationship with plasma half-life. A comparison of single vs divided dosage schedules of prazepam |
| Q39426209 | EVALUATION OF MIDAZOLAM AND DIAZEPAM FOR PRE-OPERATIVE SEDATION. |
| Q51710262 | Effect of orally administered misoprostol and cimetidine on the steady state pharmacokinetics of diazepam and nordiazepam in human volunteers |
| Q39376326 | Effects of ethanol on drug and metabolite pharmacokinetics |
| Q51849518 | Elimination kinetics and symptomatology of diazepam withdrawal in abusers. |
| Q28273994 | Elimination kinetics of desmethyldiazepam in two young and two elderly subjects |
| Q34761052 | Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis |
| Q40945993 | Fluorescence–TLC Densitometric Determination of Diazepam and Other 1,4-Benzodiazepines in Serum |
| Q37368171 | Formation of active metabolites of anticonvulsant drugs. A review of their pharmacokinetic and therapeutic significance |
| Q51695456 | Grand mal status epilepticus. |
| Q66702192 | Guide to urine testing in drug abuse prevention and multimodality treatment programs |
| Q57812222 | Hair analysis of drugs involved in drug-facilitated sexual assault and detection of zolpidem in a suspected case |
| Q66886750 | High-performance liquid chromatographic determination of benzodiazepines in human plasma |
| Q39422824 | Hypnotics. Their place in therapeutics |
| Q41112028 | Important pharmacokinetic properties of antiepileptic drugs |
| Q35672712 | Influence of age and previous use of diazepam dosage required for endoscopy |
| Q34511283 | Influence of cimetidine on oral diazepam elimination with measurement of subsequent cognitive change |
| Q28270021 | Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism |
| Q36748917 | Interpretation of oral fluid tests for drugs of abuse |
| Q51857570 | Introduction to the pharmacokinetics and pharmacodynamics of benzodiazepines |
| Q40097013 | Is chlordiazepoxide the rational choice among benzodiazepines? |
| Q51242671 | Long-term effects of benzodiazepines |
| Q51870824 | Memory and performance effects of single and 3-week administration of diazepam. |
| Q39232420 | Midazolam compared with thiopentone as a hypnotic component in balanced anaesthesia: A randomized, double-blind study |
| Q51772621 | Midazolam versus diazepam as premedication for upper gastrointestinal endoscopy: a randomized, double-blind, crossover study. |
| Q41956734 | Midazolam: second generation benzodiazepine |
| Q74410459 | Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma |
| Q39944962 | Pharmaceutical Sciences — 1973: Literature Review of Pharmaceutics |
| Q40095051 | Pharmacokinetic and Clinical Studies with a Benzodiazepine Radioreceptor Assay |
| Q36794421 | Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses |
| Q39783091 | Pharmacokinetic evaluation of hemodialysis in acute drug overdose |
| Q33700116 | Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes |
| Q34167869 | Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in Humans |
| Q28283512 | Pharmacokinetics and bioavailability of intravenous and oral chlordesmethyldiazepam in humans |
| Q48719616 | Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors |
| Q43241857 | Pharmacokinetics of N-demethyldiazepam in patients suffering from insomnia and treated with nortriptyline |
| Q39285956 | Pharmacokinetics of closely related benzodiazepines |
| Q52708114 | Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects |
| Q39168412 | Pharmacokinetics of intravenous anaesthetics: implications for clinical use. |
| Q42597665 | Pharmacokinetics of the anticonvulsant drug clonazepam evaluated from single oral and intravenous doses and by repeated oral administration |
| Q39322301 | Phenytoin intoxication during concurrent diazepam therapy |
| Q40164017 | Phenytoin: Basic and clinical pharmacology |
| Q52717101 | Plasma Levels of Diazepam After Parenteral and Rectal Administration in Children |
| Q34516648 | Plasma concentrations of diazepam and desmethyldiazepam during chronic diazepam therapy |
| Q40640453 | Plasma level monitoring of anticonvulsants |
| Q42147346 | Plasma levels of neuroleptics vs clinical response |
| Q52712237 | Plasma protein binding of diazepam and tolbutamide in chronic alcoholics. |
| Q52708498 | Plasma-diazepam in infants after rectal administration in solution and by suppository. |
| Q91865207 | Population Pharmacokinetics and Exploratory Exposure-Response Relationships of Diazepam in Children Treated for Status Epilepticus |
| Q44858911 | Potential pitfalls in the conventional pharmacokinetic studies: effects of the initial mixing of drug in blood and the pulmonary first-pass elimination |
| Q52708650 | Potentiation of Amipaque epileptogenic activity by neuroleptics |
| Q38346576 | Premedication for upper gastrointestinal endoscopy |
| Q51800026 | Reinterpretation of the pharmacokinetic mechanism of oral benzodiazepine ethanol interaction. |
| Q39145809 | Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines |
| Q42097865 | Respiratory and cardiovascular effects in relation to plasma levels of midazolam and diazepam |
| Q46122454 | Saliva and plasma concentrations of diazepam after a single oral dose |
| Q56884018 | Status epilepticus |
| Q39131737 | Steady-State Bioavailability of Two Clorazepate Dipotassium Dosage Forms |
| Q33406712 | Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam |
| Q48880067 | Subjective and behavioral effects of diazepam depend on its rate of onset |
| Q66903643 | The effect of diazepam and fentanyl on mental, psychomotor and electroencephalographic functions and their rate of recovery |
| Q51819632 | The effect of diazepam on body temperature change in humans during cold exposure. |
| Q34518465 | The effect of enzyme induction on diazepam metabolism in man |
| Q34473755 | The effects of age and liver disease on the disposition and elimination of diazepam in adult man |
| Q39161025 | The extraction and analysis of benzodiazepines in tissues by enzymic digestion and high-performance liquid chromatography |
| Q37928919 | The history of benzodiazepine dependence: a review of animal studies |
| Q41847863 | The operational multiple dosing half-life: a key to defining drug accumulation in patients and to designing extended release dosage forms |
| Q34449479 | The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration |
| Q46363007 | The role of diazepam in skin hyperpigmentation |
| Q51742997 | The use of midazolam versus propofol for short-term sedation following coronary artery bypass grafting. |
| Q52664273 | Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kinetics. |
| Q52594801 | Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. III. Peripheral bioavailability and distribution time concepts applied to the evaluation of distribution |
| Q51789381 | Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. IV. Exact relationship between the terminal log-linear slope parameter beta and drug clearance. |
| Q28326761 | Thin-layer detection of diazepam and/or chilordiazepoxide alone or in combination with major drugs of abuse in drug abuse urine screening programs |
| Q39164884 | Transplacental Passage of Diazepam Following Intravenous Injection Immediately Prior to Operative Vaginal Delivery |
| Q43626204 | Urinary excretion of diazepam metabolites in healthy volunteers and drug users |
Search more.